Skip to main content

Advertisement

SpringerLink
Log in

Interleukin-17 inhibitors in myasthenia gravis: really bad or maybe good?

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data Availability

Data sharing not applicable to this article as no datasets were generated or analysed during the current study.

References

  1. Papi C, Granata G, Galluzzo M, Iorio R (2023) Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor. Neurol Sci 44(3):1105–1107. https://doi.org/10.1007/s10072-022-06498-7

    Article  PubMed  Google Scholar 

  2. Dalakas MC (2019) Immunotherapy in myasthenia gravis in the era of biologics. Nat Rev Neurol 15(2):113–124. https://doi.org/10.1038/s41582-018-0110-z

    Article  PubMed  Google Scholar 

  3. Munera-Campos M, Ballesca F, Carrascosa JM (2018) Paradoxical reactions to biologic therapy in psoriasis: a review of the literature. Actas Dermosifiliogr (Engl Ed) 109(9):791–800. https://doi.org/10.1016/j.ad.2018.04.003

    Article  CAS  PubMed  Google Scholar 

  4. Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B et al (2014) Secukinumab in plaque psoriasis—results of two phase 3 trials. N Engl J Med 371(4):326–338. https://doi.org/10.1056/NEJMoa1314258

    Article  CAS  PubMed  Google Scholar 

  5. Blauvelt A, Prinz JC, Gottlieb AB, Kingo K, Sofen H, Ruer-Mulard M, Singh V, Pathan R, Papavassilis C, Cooper S et al (2015) Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE). Br J Dermatol 172(2):484–493. https://doi.org/10.1111/bjd.13348

    Article  CAS  PubMed  Google Scholar 

  6. Paul C, Lacour JP, Tedremets L, Kreutzer K, Jazayeri S, Adams S, Guindon C, You R, Papavassilis C, group Js, (2015) Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE). J Eur Acad Dermatol Venereol 29(6):1082–1090. https://doi.org/10.1111/jdv.12751

    Article  CAS  PubMed  Google Scholar 

  7. Kremenevski I, Sander O, Sticherling M, Raithel M, LastName FM (2022) Paradoxical reactions to biologicals in chronic inflammatory systemic diseases. Dtsch Arztebl Int 119(6):88–95. https://doi.org/10.3238/arztebl.m2022.0067

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ayala-Fontanez N, Soler DC, McCormick TS (2016) Current knowledge on psoriasis and autoimmune diseases. Psoriasis (Auckl) 6:7–32. https://doi.org/10.2147/PTT.S64950

    Article  CAS  PubMed  Google Scholar 

  9. Amanat M, Salehi M, Rezaei N (2018) Neurological and psychiatric disorders in psoriasis. Rev Neurosci 29(7):805–813. https://doi.org/10.1515/revneuro-2017-0108

    Article  PubMed  Google Scholar 

  10. Takahashi H, Tsuji H, Iizuk H (2014) Three cases of psoriasis vulgaris associated with myasthenia gravis. J Dermatol 41(5):462–463. https://doi.org/10.1111/1346-8138.12456

    Article  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Sohyeon Kim and Mi-Yeon Eun contributed equally to this work as the first authors.

Authors and Affiliations

  1. Department of Neurology, Dongsan Hospital, Keimyung University School of Medicine, 1035 Dalgubeol-Daero, Dalseo-Gu, Daegu, 42601, Korea

    Sohyeon Kim & Hung Youl Seok

  2. Department of Neurology, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Korea

    Mi-Yeon Eun

Authors
  1. Sohyeon Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mi-Yeon Eun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hung Youl Seok
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hung Youl Seok.

Ethics declarations

Ethical approval

None.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, S., Eun, MY. & Seok, H.Y. Interleukin-17 inhibitors in myasthenia gravis: really bad or maybe good?. Neurol Sci 44, 2981–2982 (2023). https://doi.org/10.1007/s10072-023-06796-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-023-06796-8

Search

Navigation